摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-benzyl-6-methoxypyridine | 332133-64-9

中文名称
——
中文别名
——
英文名称
2-benzyl-6-methoxypyridine
英文别名
——
2-benzyl-6-methoxypyridine化学式
CAS
332133-64-9
化学式
C13H13NO
mdl
——
分子量
199.252
InChiKey
PUEAMUBDFAAVEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    291.6±25.0 °C(Predicted)
  • 密度:
    1.070±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    22.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-benzyl-6-methoxypyridine氢溴酸 作用下, 以 为溶剂, 生成 2-苄基-6-羟基吡啶
    参考文献:
    名称:
    Quinuclidine compounds and drugs containing the same as the active ingredient
    摘要:
    本发明提供了一种优异的角鲨烯合成酶抑制剂。具体而言,它提供了一种由以下公式表示的化合物(I)、其盐或它们的 hydrate。 在其中,R1代表(1)氢原子或(2)羟基; HAr代表一个可以由1到3个组替换的芳香杂环; Ar代表一个可选的取代的芳香环; W代表一个由(1)-CH2-CH2-,可以替换, (2) - ch & boxH; CH - 可被取代, (3) —C≡C—, (4) - NH - CO - , (5) - CO - NH - , (6) - NH - CH2 - , (7) - CH2 - NH - , (8) - CH2 - CO - , (9) - CO - CH2 - , (10) - NH - S(O)I - , (11) - S(O)I - NH - , (12) - CH2 - S(O) - 或 (13) - S(O)I - CH2 - (I表示0、1或2); X代表由(1)单个键, (2)可选地取代的C1-6烷基链, (3)可选地取代的C2-6烯基链, (4)可选地取代的C2-6炔基链, (5)式 - Q - (其中Q代表氧原子,硫原子,CO或N(R2) (其中R2代表C1-6烷基或C1-6烷氧基)), (6) - NH - CO - , (7) - CO - NH - , (8) - NH - CH2 - , (9) - CH2 - NH - , (10) - CH2 - CO - , (11) - CO - CH2 - , (12) - NH - S(O)m - , (13) - S(O)m - NH - , (14) - CH2 - S(O)m - , (15) - S(O)m - CH2 - (其中m表示0、1或2)或(16) - (CH2) n - O - (其中n表示从1到6的整数)。
    公开号:
    US06599917B1
  • 作为产物:
    描述:
    参考文献:
    名称:
    Alternative Approach toward the Generation of Benzylic Zinc Reagent: Direct Oxidative Addition of Active Zinc into the Carbon–Oxygen Bond of Benzyl Mesylates
    摘要:
    DOI:
    10.1055/s-0034-1379880
点击查看最新优质反应信息

文献信息

  • Development of the Direct Suzuki–Miyaura Cross-Coupling of Primary <i>B</i>-Alkyl MIDA-boronates and Aryl Bromides
    作者:Jeffrey D. St. Denis、Conor C. G. Scully、C. Frank Lee、Andrei K. Yudin
    DOI:10.1021/ol500057a
    日期:2014.3.7
    The development of a palladium-catalyzed sp3–sp2 Suzuki–Miyaura cross-coupling of B-alkyl-N-methyliminodiacetyl (B-alkyl MIDA) boronates and (hetero)aryl bromides is reported. This transformation is tolerant of a variety of functional groups (F, NO2, CN, Cl, COCH3, and CHO). B-Alkyl MIDA boronates allow an efficient cross-coupling reaction directed toward the synthesis of unsymmetrical methylene diaryls
    发展的钯-催化的SP 3 -sp 2铃木-宫浦交叉偶合B-烷基Ñ -methyliminodiacetyl(乙-烷基MIDA)硼酸酯和(杂)芳基溴化物进行报告。这种转化耐受各种官能团(F,NO 2,CN,Cl,COCH 3和CHO)。B-烷基MIDA硼酸酯可实现高效的交叉偶联反应,以高收率或优异收率合成不对称的亚甲基二芳基以及烷基化的芳烃。
  • Quinuclidine compounds and drugs containing the same as the active ingredient
    申请人:Eisai Co., Ltd.
    公开号:US06599917B1
    公开(公告)日:2003-07-29
    The present invention provides an excellent squalene synthesizing enzyme inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them. In which R1 represents (1) hydrogen atom or (2) hydroxyl group; HAr represents an aromatic heterocycle which may be substituted with 1 to 3 groups; Ar represents an optionally substituted aromatic ring; W represents a chain represented by (1) —CH2—CH2— which may be substituted, (2) —CH═CH— which may be substituted, (3) —C≡C—, (4) —NH—CO—, (5) —CO—NH—, (6) —NH—CH2—, (7) —CH2—NH—, (8) —CH2—CO—, (9) —CO—CH2—, (10) —NH—S(O)l—, (11) —S(O)l—NH—, (12) —CH2—S(O)— or (13) —S(O)l—CH2— (l denotes 0, 1 or 2); and X represents a chain represented by (1) a single bond, (2) an optionally substituted C1-6 alkylene chain, (3) an optionally substituted C2-6 alkenylene chain, (4) an optionally substituted C2-6 alkynylene chain, (5) a formula —Q— (wherein Q represents oxygen atom, sulfur atom, CO or N(R2) (wherein R2 represents a C1-6 alkyl group or a C1-6 alkoxy group)), (6) —NH—CO—, (7) —CO—NH—, (8) —NH—CH2—, (9) —CH2—NH—, (10) —CH2—CO—, (11) —CO—CH2—, (12) —NH—S(O)m—, (13) —S(O)m—NH—, (14) —CH2—S(O)m—, (15) —S(O)m—CH2— (wherein m denotes 0, 1 or 2) or (16) —(CH2)n—O— (wherein n denotes an integer from 1 to 6).
    本发明提供了一种优异的角鲨烯合成酶抑制剂。具体而言,它提供了一种由以下公式表示的化合物(I)、其盐或它们的 hydrate。 在其中,R1代表(1)氢原子或(2)羟基; HAr代表一个可以由1到3个组替换的芳香杂环; Ar代表一个可选的取代的芳香环; W代表一个由(1)-CH2-CH2-,可以替换, (2) - ch & boxH; CH - 可被取代, (3) —C≡C—, (4) - NH - CO - , (5) - CO - NH - , (6) - NH - CH2 - , (7) - CH2 - NH - , (8) - CH2 - CO - , (9) - CO - CH2 - , (10) - NH - S(O)I - , (11) - S(O)I - NH - , (12) - CH2 - S(O) - 或 (13) - S(O)I - CH2 - (I表示0、1或2); X代表由(1)单个键, (2)可选地取代的C1-6烷基链, (3)可选地取代的C2-6烯基链, (4)可选地取代的C2-6炔基链, (5)式 - Q - (其中Q代表氧原子,硫原子,CO或N(R2) (其中R2代表C1-6烷基或C1-6烷氧基)), (6) - NH - CO - , (7) - CO - NH - , (8) - NH - CH2 - , (9) - CH2 - NH - , (10) - CH2 - CO - , (11) - CO - CH2 - , (12) - NH - S(O)m - , (13) - S(O)m - NH - , (14) - CH2 - S(O)m - , (15) - S(O)m - CH2 - (其中m表示0、1或2)或(16) - (CH2) n - O - (其中n表示从1到6的整数)。
  • The Dual Role of Benzophenone in Visible-Light/Nickel Photoredox-Catalyzed C−H Arylations: Hydrogen-Atom Transfer and Energy Transfer
    作者:Abhishek Dewanji、Patricia E. Krach、Magnus Rueping
    DOI:10.1002/anie.201901327
    日期:2019.3.11
    A dual catalytic protocol for the direct arylation of non‐activated C(sp3)−H bonds has been developed. Upon photochemical excitation, the excited triplet state of a diaryl ketone photosensitizer abstracts a hydrogen atom from an aliphatic C−H bond. This inherent reactivity was exploited for the generation of benzylic radicals which subsequently enter a nickel catalytic cycle, accomplishing the benzylic
    已经开发了用于未活化的C(sp 3)-H键直接芳基化的双重催化方案。在光化学激发下,二芳基酮光敏剂的激发三重态从脂肪族CH键中提取氢原子。利用这种固有的反应性来产生苄基,其随后进入镍催化循环,从而完成苄基芳基化。
  • Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity
    作者:Zhen Liu、Yuan Yao、Mari Kogiso、Baisong Zheng、Lisheng Deng、Jihui J. Qiu、Shuo Dong、Hua Lv、James M. Gallo、Xiao-Nan Li、Yongcheng Song
    DOI:10.1021/jm500660f
    日期:2014.10.23
    total of 61 derivatives were synthesized, and their structure–activity relationships were investigated. Potent IDH1(R132H) inhibitors were identified with Ki values as low as 140 nM, while they possess weak or no activity against WT IDH1. Activities of selected compounds against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular production
    异柠檬酸脱氢酶 1 (IDH1) 的突变常见于某些癌症,例如神经胶质瘤。与野生型 (WT) IDH1 不同,突变酶催化 α-酮戊二酸还原为d -2-羟基戊二酸 (D2HG),从而引发癌症。几种 1-hydroxypyridin-2-one 化合物被鉴定为 IDH1(R132H) 的抑制剂。共合成了 61 种衍生物,并研究了它们的构效关系。用K i鉴定了有效的 IDH1(R132H) 抑制剂值低至 140 nM,而它们对 WT IDH1 具有弱活性或无活性。发现所选化合物对 IDH1(R132C) 的活性与其对 IDH1(R132H) 的抑制活性以及 D2HG 的细胞产生相关,R 2分别为 0.83 和 0.73。在基于细胞的模型测定中发现几种抑制剂可渗透血脑屏障,并对具有IDH1 R132H 突变的神经胶质瘤细胞表现出有效的选择性活性(EC 50 = 0.26–1.8 μM)。
  • N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
    申请人:——
    公开号:US20040072830A1
    公开(公告)日:2004-04-15
    The present invention provides an excellent squalene synthase inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them. 1 wherein R 1 represents an optionally substituted vinyl group or an aromatic ring which may be substituted; n is an integer of 0 to 2; X, Y and Z are the same as or different from each other and each represents an optionally substituted carbon atom, or an optionallysubstitutednitrogenatom, sulfuratomoroxygenatom, and Y optionally represents a single bond, and when Y represents the single bond, the ring to which X, Y and Z belong is a 5-membered ring; CyA represents a 5- to 14 membered non-aromatic cyclic amino groupornon-aromatic cyclic amidogroupwhichmaybe substituted, and the non-aromatic cyclic amino group or the non-aromatic cyclic amido group optionally having an oxygen atom or a sulfur atom; W represents a chain expressed by (1) optionally substituted -CH 2 -CH 2 -, (2) optionally substituted -CH=CH-, (3) -C-C-, (4) an optionally substituted phenylene group, (5) a single bond, (6) -NH-CO-, (7) -CO-NH-, (8) -NH-CH 2 -, (9) -CH 2 -NH-, (10) -CH 2 -CO-, (11) -CO-CH 2 -, (12) -O-(CH 2 ) m 1 (13) - (CH 2 ) -O- (where m represents an integer of 0 to 5), (14) -O-CH 2 -CR 2 =1 (15) -O-CH 2 -CHR 2 - (where R 2 represents a hydrogen atom, a C 16 alkyl group or a halogen atom), (16) -NH-S(O)l-, (17) -S(O)3l-NH-, (18) -CH 2 -S(°) 1 -. or (19) -S(O),-CH 2 - (where 1 represents 0, 1, or 2); and A represents a group having any of the following structural formulae: 2 (wherein R 3 and R 4 represent independently a hydrogen atom or an optionally substituted C 16 alkyl group, or combine through a carbon chain optionally containing a heteroatom to form a ring; R 5 and R 6 represent independently a hydrogen atom or an optionally substituted C 16 alkyl group, or combine through a carbon chain optionally containing a heteroatom to form a ring; R 7 represents a hydrogen atom, an optionally substituted C 16 alkyl group, a hydroxyl group, an alkoxy group, a halogen atom or an optionally substituted amino group; R 8 represents a hydrogen atom, a hydroxyl group, an alkoxy group, a halogen atom or an optionally substituted amino group; B1 represents an optionally substituted carbon atom, or an optionallysubstitutednitrogenatom, oxygenatomorsulfuratom; B2 represents an optionally substituted carbon atom or nitrogen atom; a and b represent an integer of 0 to 4, provided that a+b is an integer of 0 to 4; c represents 0 or 1; and 3 represents a single bond or a double bond, provided that when c is 1 in which A is a quinuclidine having R 8 represented by 4 the case where R 8 is a hydrogen atom or a hydroxyl group; Arl is an aromatic heterocycle; and W is one of (1) to (3), (6) to (11) and (16) to (19) are excluded).
    本发明提供了一种出色的角鲨烷合成酶抑制剂。具体地,提供了以下式子所表示的化合物(I),其盐或水合物。 其中,R1表示可以被取代的乙烯基或可以被取代的芳香环,n为0至2的整数;X、Y和Z相同或不同,每个表示可以被取代的碳原子、可以被取代的氮原子、硫原子或氧原子,Y可以表示单键,当Y表示单键时,X、Y和Z所属的环是一个五元环;CyA表示一个5-至14个成员的非芳香环状氨基团或非芳香环状酰胺基团,其可以被取代,非芳香环状氨基团或非芳香环状酰胺基团可以选择具有氧原子或硫原子;W表示由以下式子表示的链: (1)可以被取代的-CH2-CH2-, (2)可以被取代的-CH=CH-, (3)-C-C-, (4)可以被取代的苯基, (5)单键, (6)-NH-CO-, (7)-CO-NH-, (8)-NH-CH2-, (9)-CH2-NH-, (10)-CH2-CO-, (11)-CO-CH2-, (12)-O-(CH2)m1(其中m表示0至5的整数), (13)-(CH2)-O-(其中m表示0至5的整数), (14)-O-CH2-CR2=1, (15)-O-CH2-CHR2-(其中R2表示氢原子、C16烷基或卤素原子), (16)-NH-S(O)l-, (17)-S(O)3l-NH-, (18)-CH2-S(°)1-或 (19)-S(O),-CH2-(其中l表示0、1或2); A表示以下结构式之一的基团: (其中,R3和R4独立地表示氢原子或可以被取代的C16烷基,或通过可选含有杂原子的碳链结合形成环;R5和R6独立地表示氢原子或可以被取代的C16烷基,或通过可选含有杂原子的碳链结合形成环;R7表示氢原子、可以被取代的C16烷基、羟基、烷氧基、卤素原子或可以被取代的氨基团;R8表示氢原子、羟基、烷氧基、卤素原子或可以被取代的氨基团;B1表示可以被取代的碳原子、可以被取代的氮原子、氧原子或硫原子;B2表示可以被取代的碳原子或氮原子;a和b表示0至4的整数,前提是a+b是0至4的整数;c表示0或1;3表示单键或双键,当c为1时,A为具有R8由4表示的喹啉环的情况除外,Arl为芳香杂环,而W为(1)至(3)、(6)至(11)和(16)至(19)中的一种。
查看更多